Achilles therapeutics reports second quarter 2023 financial results and recent business highlights

- clinical and translational science data expected in the fourth quarter of 2023 from the ongoing phase i/iia trials in nsclc and melanoma -
ACHL Ratings Summary
ACHL Quant Ranking